EUVIMEDEUVIMED entdecken
Crossref

Overweight Impairs Escalating Optimal Methotrexate Dose and Effect via Liver Dysfunction in Japanese Patients With Rheumatoid Arthritis

Soshi Takahashi iD, Miho Shibata, Miho Takahashi iD, Ayano Mori iD, Saori Hatachi, Toshiharu Saito, Shunichi Kumagai

International Journal of Rheumatic Diseases · 2025

DOI: 10.1111/1756-185x.70487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Rheumatic Diseases, 2025. Verfasst von Soshi Takahashi und 6 weiteren Autor:innen. Beteiligte Einrichtung: The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Methotrexate, Overweight, Antirheumatic Agents. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

To evaluate the impact of overweight on methotrexate (MTX) efficacy and liver function in Japanese patients with rheumatoid arthritis (RA), and to explore whether liver dysfunction contributes to MTX dose limitation and treatment resistance in overweight individuals.

Methods

This retrospective cohort study included 71 RA patients who initiated MTX at a single center in Japan between April 2016 and December 2021. Patients were stratified by body mass index (BMI) into normal weight (< 25.0 kg/m 2 ) and overweight (≥ 25.0 kg/m 2 ) groups. Clinical data including DAS28‐CRP, liver enzyme levels, and MTX dosing were assessed at baseline and at 12, 24, and 48 weeks. The primary outcome was the change in DAS28‐CRP (ΔDAS28‐CRP) over time. Non‐parametric tests were used for comparisons.

Results

The overweight group showed significantly smaller ΔDAS28‐CRP at 24 and 48 weeks ( p < 0.05), suggesting a reduced clinical response to MTX, potentially related to lower MTX dose per body weight and elevated liver enzymes limiting dose escalation. While absolute MTX doses were similar, MTX dose per body weight was significantly lower in the overweight group throughout the study ( p < 0.05). MTX dose per body weight was negatively correlated with DAS28‐CRP at 48 weeks ( r = −0.285, p = 0.016). Overweight patients had higher AST, ALT, and γ‐GTP levels, and a greater prevalence of fatty liver, suggesting liver dysfunction may have limited MTX escalation. Tender joint counts and CRP levels remained elevated in the overweight group, independent of osteoarthritic changes.

Conclusion

Overweight was associated with reduced MTX response in Japanese RA patients, potentially due to elevated liver enzymes limiting MTX dose escalation and leading to suboptimal dosing per body weight. Weight management and lifestyle interventions may improve treatment outcomes in overweight RA patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidMethotrexateOverweightAntirheumatic AgentsLiverChemical and Drug Induced Liver InjuryHumansMaleFemaleRetrospective StudiesMiddle AgedJapanAgedTreatment OutcomeDose-Response Relationship, DrugBody Mass IndexEast Asian People

Stichwörter der Autor:innen

DAS28‐CRPbody mass indexliver dysfunctionmethotrexateoverweightrheumatoid arthritis

Substanzen

MethotrexateAntirheumatic Agents

Autor:innen und Institutionen

  • The Shinko Institute for Medical Research, Shinko Hospital, Kobe, Japan.
  • The Center for Rheumatic Disease, Shinko Hospital, Kobe, Hyogo, Japan.

ORCID-Profile: Soshi Takahashi, Miho Takahashi, Ayano Mori

Zitieren

APA

Takahashi, S., Shibata, M., Takahashi, M., Mori, A., Hatachi, S., Saito, T., & Kumagai, S. (2025). Overweight Impairs Escalating Optimal Methotrexate Dose and Effect via Liver Dysfunction in Japanese Patients With Rheumatoid Arthritis. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.70487

Vancouver

Takahashi S, Shibata M, Takahashi M, Mori A, Hatachi S, Saito T, et al. Overweight Impairs Escalating Optimal Methotrexate Dose and Effect via Liver Dysfunction in Japanese Patients With Rheumatoid Arthritis. International Journal of Rheumatic Diseases. 2025. doi:10.1111/1756-185x.70487

BibTeX
@article{Takahashi2025,
  author = {Takahashi, Soshi and Shibata, Miho and Takahashi, Miho and Mori, Ayano and Hatachi, Saori and Saito, Toshiharu and Kumagai, Shunichi},
  title = {Overweight Impairs Escalating Optimal Methotrexate Dose and Effect via Liver Dysfunction in Japanese Patients With Rheumatoid Arthritis},
  journal = {International Journal of Rheumatic Diseases},
  year = {2025},
  doi = {10.1111/1756-185x.70487}
}
Kostenlos starten →